You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

Article Text

Article menu
Download PDFPDF
ABSTRACT: Oral Poster Presentations: Cervical Cancer Tuesday, October 17, 2006
0073: A Danish Gynaecologic Cancer Group (DGC) Phase II Study of Salvage Treatment of Early Relapsed Epithelial Ovarian Cancer (OC) By Gemcitabine (GEM) and Pegylated Liposomal Doxorubicin (PLD)

https://doi.org/10.1136/ijgc-00009577-200610001-00073

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    This is a PDF-only article. The first page of the PDF of this article appears above.